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1  | INTRODUC TION
Over	the	past	few	years,	the	transplant	community	has	made	great	
efforts	 to	 increase	 the	 pediatric	 priority	 in	 liver	 organ	 allocation;	
however,	the	mortality	of	children	candidates	for	 liver	transplanta‐
tion	(LT),	who	are	disadvantaged	because	of	the	lack	of	size‐matched	
donors,	 has	 been	 steady	 at	 approximately	 10%	every	 year.1,2 Split 



















This	 study	aims	 to	analyze	 liver	allocation	 in	 Italy	after	 the	 in‐
troduction	of	the	new	SLP	and	its	impact	on	the	pediatric/adult	LT‐ 
waiting	list	and	on	SLT	outcomes.
2  | MATERIAL S AND METHODS






At	 that	 time,	 donors	 aged	 ≤14	years	were	 preferentially	 allocated	 to	









To	 implement	 split	 liver	 transplantation	 (SLT)	 a	 mandatory‐split	 policy	 has	 been	
adopted	in	Italy	since	August	2015:	donors	aged	18‐50	years	at	standard	risk	are	of‐
fered	 for	SLT,	 resulting	 in	a	 left‐lateral	 segment	 (LLS)	graft	 for	children	and	an	ex‐
tended‐right	 graft	 (ERG)	 for	 adults.	 We	 aim	 to	 analyze	 the	 impact	 of	 the	 new	













vorable	 impact	 on	 the	 pediatric	 LT‐waiting	 list	 and	 priority	 for	 adult	 sick	 LT	
candidates.









Italian	 Score	 for	 Organ	 Allocation	 (ISO),	 which	 is	 defined	 by	 bio‐
chemical	MELD	and	exceptions.14	At	present,	liver	grafts	are	shared	
according	 to	 the	 following	principles:	 (1)	nationwide,	 for	 (a)	UNOS	
status	1	patients;	(b)	pediatric	candidates	according	to	the	pediatric	
LT	allocation	system15;	(2)	macro‐areas	for	adult	LT	candidates	with	














This	 study	 analyzed	 all	 deceased	donors	 used	 in	 Italy	 for	 LT	 after	
the	introduction	of	the	new	SLP	and	all	recipients	transplanted	with	
LLSs	 and	 ERGs	 derived	 from	 split	 procedures.	 For	 the	 outcome	
analysis,	the	same	number	of	SLTs	performed	consecutively	before	
the	 introduction	 of	 the	 new	 SLP	was	 used	 as	 a	 control	 group.	 To	
evaluate	the	 impact	of	 the	new	SLP,	data	from	adult	and	pediatric	
LT‐waiting	lists	as	well	as	data	on	living	donor	liver	transplantation	
(LDLT)	 activity	 were	 considered.	 Organ	 allocation,	 donor,	 recipi‐
ent,	 and	 surgical	 data	 were	 recovered	 from	 the	 CNT	 prospective	





































Adult donor ( 18 years) 
Adult recipient with 
MELD 30? Allocation as WLG* 
Donor aged 18-50 years with Allocation as WLG 
Donor offered to Pediatric LT 
candidates as split liver graft
splittable
suitable for Pediatric 
LT candidates 
splittable
Pediatric LT candidate 
LLS graft allocated to Pediatric LT 
candidate 
ERG allocated to adult LT candidate according to 
regional and macro-area organ allocation 
Pediatric donor (<18 years) 
Donor accepted for Pediatric 
LT candidates* 
Donor offered to Pediatric LT candidates 
Donor not accepted for 





*The assigned transplant center may decide to split or not the graft, in
that case the LLS is offered to Pediatric LT candidates
       Nationwide organ allocation 
        Macro-area organ allocation 
        Regional organ allocation 
Recipient with Status UNOS 1?
Yes 


















<.05	 was	 considered	 significant.	 Normal	 distribution	 continuous	




3.1 | Liver allocation and split liver procurement
Between	August	2015	and	December	2016,	1537	cadaveric	donors	
were	used	 for	LT,	 including	58	 (3.8%)	pediatric	donors	 (<18	years),	
1066	 (69.4%)	 adults	 >50	years	 and/or	 nonstandard	 risk,	 and	 413	
(26.8%)	 adults	 aged	 18‐50	years	 with	 standard	 risk.	 In	 the	 latter	
group,	161	(39%)	donors	were	allocated	to	UNOS	status	1	or	MELD	
≥30	 patients;	 the	 remaining	 252	 (61%)	were	 proposed	 for	 SLT,	 of	
whom	53	(21%)	were	accepted.	One	hundred	and	one	(40.1%)	were	
excluded	 from	 split	 because	 of	 the	 clinical	 characteristics	 of	 the	
donor	at	 the	 time	of	offer	 (n	=	85)	or	at	 laparotomy	 (n	=	16).	 In	88	
cases	 (34.9%),	 the	split	procedure	was	not	performed	 for	absence	

























aged	 18‐50	years,	 11	 (16.2%)	 in	 donors	 <18	years,	 and	 8	 (11.8%)	
in	donors	>50	years	 (Table	3).	These	were	standard	split	 liver	pro‐
cedures	 in	66	 (97.1%)	 cases	 and	 full‐left/full‐right	 split	 in	2	 (2.9%)	
cases.	One	LLS	graft	was	not	transplanted	because	of	vascular	 in‐
jury.	 Similar	 to	 the	 study	 group,	 left	 and	 right	 lobes	 and	one	ERG	
used	 for	 combined	 liver‐pancreas	 transplantation	 were	 excluded,	
resulting	in	65	LLSs	and	65	ERGs	enrolled	in	the	study.





3.2.1 | Left‐lateral segment graft transplantation
Table	5	 shows	 the	 surgical	 and	 recipient	 characteristics	 of	 LLS	
transplantation.	During	 the	 study	 period,	 the	 LLS	 recipients	were	























ITU,	 intensive	 therapy	 unit;	 LFTs,	 liver	 function	 tests;	 US	 scan,	 ultra‐
sound	scan.
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significantly	 younger	 compared	 to	 those	 transplanted	 in	 the	 con‐












Within	 the	 first	 year	of	SLT,	postoperative	 technical	 complica‐
tions	were	comparable	in	the	two	periods	(20	[30.3%]	vs	24	[36.9%],	
[P	=	.529])	(Table	S3).
3.2.2 | Extended right graft transplantation
The	 technical	 and	 recipient	 characteristics	 of	 ERG	 transplantation	

















Donor refused for donor 
characteristicsa 
Donor refused for absence of 
suitable recipientsa 
Donors accepted 
for SLT P value
Number	(%) 252 101	(40.1%) 98	(38.9%) 53	(21%) ‐
Age	(years) 41	(18‐50) 43.5	(18‐50) 41	(18‐50) 38	(18‐50) .044
Gender	(female) 88	(34.9%) 38	(37.6%) 29	(29.6%) 21	(39.6%) .366
BMI 25	(16‐46) 25	(18‐46) 26	(18‐46) 24	(18‐32) <.0001
Weight	(kg) 75	(30‐150) 75	(42‐120) 80	(30‐150) 70	(50‐90) <.0001
Height	(cm) 170	(130‐192) 170	(146‐190) 175	(130‐192) 170	(150‐190) .158
Blood	group
0 94	(37.3%) 45	(44.6%) 22	(22.4%) 27	(50.9%)
A 103	(40.9%) 37	(36.7%) 50	(51.0%) 16	(30.2%)
AB 14	(5.6%) 5	(4.9%) 9	(9.2%) 0	(%) .002
B 41	(16.3%) 14	(13.9%) 17	(17.3%) 10	(18.9%)
Use	of	vasopressors	
(yes)
198	(78.6%) 76	(75.2%) 69	(70.4%) 42	(86.8%) <.0001
Use	>1	vasopressors 49	(19.4%) 25	(24.8%) 13	(13.3%) 11	(20.8%) .088
ITU	stay	(days) 3	(0‐37) 2	(0‐37) 3	(0‐16) 3	(0‐19) .648
AST	(U/L) 45	(7‐15285) 55	(9‐15285) 40	(7‐497) 42	(9‐628) .023
ALT	(U/L) 41	(5‐5575) 56	(6‐5575) 32	(5‐971) 34	(9‐530) .035
Total	bilirubin	(mg/dL) 0.4	(0.1‐7.8) 0.4	(0.1‐7.8) 0.4	(0.1‐3.04) 0.3	(0.1‐2.6) .038
GGT	(U/L) 39	(5‐988) 42	(5‐988) 33	(8‐537) 33	(5‐624) .378
Serum	sodium	
(mmL/L)




112	(44.4%) 40	(39.6%) 46	(46.9%) 26	(49.1%)
Trauma 93	(36.9%) 38	(37.6%) 37	(37.8%) 18	(34%) .248
Anoxia 38	(15.1%) 20	(19.8%) 12	(12.2%) 6	(11.3%)
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Among	 LLS	 transplantation,	 re‐transplantation	 vs	 first	 trans‐
plantation	 (HR	=	3.349,	P	=	.006),	 recipient	 body	weight	 >20	kg	 vs	
≤20	kg	 (HR	=	4.088,	P	=	.001),	 and	 donor‐to‐recipient	weight	 ratio	
(DRWR)	≤4	vs	>4	(HR	=	1.380,	P	=	.018)	were	risk	factors	for	graft	
failure	by	univariate	analysis	(Table	S7).	In	the	multivariate	analysis,	
recipient	body	weight	>20	kg	vs	≤20	kg	 (HR	=	5.113,	P = .048) and 
retransplantation	as	an	indication	of	SLT	(HR	=	2.641,	P	=	.035)	were	
predictors	of	graft	failure	(Figures	S1,	S2).
In	 ERG	 transplantation,	 cold	 ischemic	 time	 (CIT)	 >8	hours	 vs	
≤8	hours	 (HR	=	2.574,	 P	=	.039)	 and	 donor	 ITU‐stay	 >5	days	 vs	
≤5	days	 (HR	=	1.946,	 P	=	.046)	 were	 identified	 as	 risk	 factors	 for	
graft	 loss	 according	 to	 the	univariate	 analysis	 (Table	S8),	 and	only	
CIT	>8	hours	vs	≤8	hours	(HR	=	2.475,	P	=	.048)	 in	the	multivariate	
analysis	(Figure	S3).






During	 the	 study	 period,	 114	pediatric	 LTs	were	 performed,	
including	 75	 (65.8%)	 SLTs,	 34	 (29.8%)	 whole	 LTs,	 and	 5	 (4.4%)	
LDLTs.	 During	 the	 control	 period,	 150	 pediatric	 LTs	 were	 per‐
formed,	 including	 74	 (49.3%)	 SLTs,	 51	 (34%)	 whole	 LTs,	 and	 25	
(16.7%)	LDLTs.
After	the	introduction	of	the	new	SLP,	the	total	number	of	chil‐
dren	receiving	a	split	graft	increased	from	49.3%	to	65.8%	(P = .009) 
and	the	LDLT	rate	significantly	reduced	compared	to	the	control	pe‐
riod	(4.4%	vs	16.7%,	P	=	.0016).
The	 median	 time	 on	 the	 LT‐waiting	 list	 reduced	 from	 229	
(10‐2121)	days	to	80	(12‐2503)	days	(P	=	.045).	Child	dropout	from	

























Improving	 SLT	 programs	 has	 attracted	 great	 interest	 in	 recent	
years	as	a	method	of	 reducing	pediatric	LT‐waiting	 list	mortality.10 





Old split liver 
policy P value
Number 66 65




Gender	(female) 25	(51%) 24	(49%) 1.000
BMI 23	(16‐32) 23	(19‐33) .692






A 22	(33.3%) 30	(46.2%) .211
B 10	(15.2%) 5	(7.7%)




ITU	stay	(days) 3	(0‐19) 2	(0‐11) .039*
AST	(U/L) 40	(9‐628) 42	(8‐357) .639
ALT	(U/L) 29	(9‐530) 34	(8‐269) .978
Total	bilirubin	(mg/dL) 0.5	(0.1‐3) 0.4	(0.1‐8) .078








Trauma 24	(36.4%) 21	(32.3%) .632
Anoxia 7	(10.6%) 10	(15.4%)
Others 4	(6.1%) 1	(1.5%)
ALT,	 alaninoaminotransferase;	 AST,	 aspartatoaminotransferase;	 GGT,	
gamma‐glutamyltransferase;	BMI,	body	mass	index;	ITU,	intensive	ther‐
apy	unit.
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Although	the	SLT	rate	constantly	 increased	 in	Europe	 (>400	SLTs/
year	 since	 2002),18	 a	 change	 in	 donor	 demographics	 resulted	 in	 a	
reduction	of	deceased	liver	donors	suitable	for	split	procedures.	The	











major	 steps:	 first,	 the	 CNT	 offers	 all	 donors	 aged	 18‐50	years	 at	
standard	 risks	 to	 the	 pediatric	 transplant	 centers	 for	 SLT;	 second,	
the	pediatric	transplant	centers	decide	if	the	LLS	is	suitable	for	pedi‐
atric	LT	candidates;	and	third,	the	ERG,	which	is	considered	ab	initio	
fit	 for	 transplantation	 as	 the	pediatric	 donor	 selection	 criteria	 are	
more	narrowing	 than	 those	adopted	 for	adults,	 is	 allocated	 to	 the	
Variables
New split liver policy 
(n = 66)
Old split liver policy 
(n = 65) P value
Surgical	variables
In	situ/ex	situ	split 64	(97%)	/	2	(3%) 63	(96.9%)	/	2	(3.1%) 1.000





Age	(years) 1.1	(0.1‐11.2) 2.1	(0.1‐12.1) .043
Gender	(female) 33	(50%) 36	(55.4%) .601
BMI 16.4	(13	‐23.8) 16.5	(11.3‐22.3) .848
Weight	(kg) 8.7	(4‐35) 12	(6‐30) .020
Height	(cm) 70.1	(53‐135) 84	(58‐152) .014
Blood	group
0 28	(42.4%) 22	(33.8%)
A 23	(34.8%) 33	(50.8%) .271
B 12	(18.2%) 7	(10.8%)
AB 3	(4.5%) 3	(4.6%)

























TA B L E  5  Surgical	and	recipient	
characteristics	of	left‐lateral	segment	
transplantation
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best‐matching	adult	recipient.	Subsequently,	the	graft	“splittability”	
remains	only	a	technical	aspect	(ie,	vascular	anomalies).
In	 the	 study	 period,	 donors	 within	 SLT‐criteria	 accounted	 for	
26%	of	all	 liver	donors,	of	which	60%	were	offered	for	SLT	and	of	
these,	21%	were	effectively	used	for	SLT.	Consequently,	the	intro‐
duction	of	 the	new	SLP	 significantly	 increased	 the	number	of	do‐



























F I G U R E  3  Patient	(A)	and	graft	(B)	survival	of	left‐lateral	segment	transplantation






Old split liver 
policy (n = 65) P value
Total	number	of	death 10	(15.2%) 7	(10.8%) .456
Cause	of	death
PNF 1	(1.5%) 2	(3.1%) .619
Sepsis 2	(3.0%) 1	(1.5%) .568
MOF 5	(7.6%) 2	(3.1%) .077
Tumor	recurrence 0	(0%) 1	(1.5%) 1.000
Pulmonary	embolism 1	(1.5%) 0	(1.5%) .496




Retransplantation 4	(6.1%) 5	(7.7%) .712
Cause	of	retransplantation







Chronic	rejection 0	(0%) 1	(1.5%) .312
DNF,	delayed	nonfunction;	 LLS,	 left‐lateral	 segment;	MOF,	multiorgan	
failure;	PNF,	primary	nonfunction.





















TA B L E  7  Surgical	and	recipient	 characteristics	of	extended	right	graft	transplantation
Variables
New split liver policy 
(n = 65)
Old split liver policy 
(n = 65) P value
Surgical	variables
In	situ/ex	situ	split 58	(89.2%)/7	(10.8%) 59	(90.8%)/6	(9.2%) .778
Cold	ischemic	time	(hours) 7	(4‐11) 6	(3‐15) .125
Warm	ischemic	time	(minutes) 42	(22‐165) 35	(22‐80) .207
Recipient variables
Age	(years) 53	(2‐71) 53	(8‐69) .714
Gender	(female) 29	(44.6%) 38	(58.5%) .160
BMI 23.2	(13.4‐32) 23.5	(14.3‐43.3) .257
Weight	(kg) 64	(11‐103) 65	(22‐109) .782




B 12	(18.5%) 6	(9.2%) .040
AB 1	(1.5%) 1	(1.5%)
Biochemical	MELD/PELD 18	(10‐35) 20	(9‐42) 1.000
UNOS	status
1 2	(3.1%) 3	(4.6%)
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was	also	essential	to	implement	the	national	SLT	programme.20	The	

























didates	 significantly	 improved	 (proportionally	 to	 the	 Italian	 donation	
rate),	giving	more	opportunities	 to	children	 to	 receive	SLT;	 in	conse‐
quence	the	median	pediatric	LT‐waiting	list	time	significantly	decreased	
(from	 7	months	 to	 less	 than	 3	months),	 being	 considerably	 shorter	
compared	to	other	series	(ie,	in	the	US	>40%	of	children	spend	over	a	
year	on	the	waiting	list).45	Likewise,	the	pediatric	LT‐waiting	list	mor‐
tality	 rate	 was	 2.5%,	 remarkably	 lower	 compared	 to	 other	 reports	
(7‐12%),1,2,10	and	in	half	of	the	cases	death	occurred	in	children	awaiting	
urgent	re‐LT.	Because	in	Italy	the	majority	of	children	are	transplanted	
F I G U R E  4  Patient	(A)	and	graft	(B)	survival	of	extended	right	graft	transplantation
TA B L E  8  Causes	of	death	and	retransplantation	after	extended	
right	graft	transplantation
Variables
New split liver 
policy (n = 65)
Old split liver 









Tumor	recurrence 1	(1.5%) 1	(1.5%) 1.000
MOF 0	(0%) 2	(3%) .496
Retransplantation 5	(7.7%) 7	(10.8%) .638
Cause	of	retransplantation










































and	MELD	≥30	adult	 candidates	 ensure	 that	mandatory	SLP	does	
not	harm	 the	adult	 LT‐waiting	 list.	 Split	 liver	donor	 criteria	 can	be	
safely	expanded,	providing	optimal	graft	and	patient	SLT	outcomes.	
Thus,	 a	 significant	 proportion	 of	 potentially	 “splittable”	 donors	 is	
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